101 results
8-K
EX-99.1
EVOK
Evoke Pharma Inc
14 May 24
Evoke Pharma Reports First Quarter 2024 Financial Results
4:15pm
of nasal metoclopramide in women with gastroparesis, highlighting its benefits and practical application,” Mr. D’Onofrio concluded.
Fourth Quarter
424B3
0btdey ewy
14 Mar 24
Prospectus supplement
6:44pm
8-K
EX-99.1
ad9uxd4jcbnbxv3y
14 Mar 24
Evoke Pharma Reports Fourth Quarter and Full Year 2023 Financial Results
4:00pm
8-K
EX-4.1
j54vw5hxsgj0j9t7c
14 Feb 24
Unregistered Sales of Equity Securities
9:00am
8-K
EX-1.1
h8cqnmb ock2dslo4
9 Feb 24
Evoke Pharma Announces Pricing of Underwritten Public Offering of up to $30 Million
5:15pm
424B4
t2fm0
9 Feb 24
Prospectus supplement with pricing info
5:14pm